MONTREAL--(Marketwire - November 29, 2007) - TOPIGEN Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company specializing in respiratory diseases, today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will participate in the BMO Capital Markets Focus on Healthcare Conference and the RBC Capital Markets 2007 Healthcare Conference, both to be held in New York, NY. Dr. Wotton will be available for one-on-one meetings during both conferences.
